Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions

Neurology

Volumn 64, Issue 5, 2005, Pages 834-841

  Bennett, D A ^a   Schneider, J A ^a   Bienias, J L ^b   Evans, D A ^b   Wilson, R S ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; PARAFFIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN INFARCTION; CLERGY; COGNITION; COGNITIVE DEFECT; DEATH; DEMENTIA; DIFFUSE LEWY BODY DISEASE; ENTORHINAL CORTEX; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGICAL TEST; PARIETAL LOBE; PLAQUE FORMING CELL; PRIORITY JOURNAL; SILVER STAINING; SUBSTANTIA NIGRA; TEMPORAL LOBE; TISSUE SECTION;

EID: 14644416500     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000152982.47274.9E     Document Type: Article

References (39)

1. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-1142.
2. Unverzagt FW, Gao S, Baiyewu O, et al. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001;57:1655-1662.
3. Artero S, Touchon J, Ritchie K. Disability and mild cognitive impairment: a longitudinal population-based study. Int J Geriatr Psychiatry 2001;16:1092-1097.
4. Griffith HR, Belue K, Sicola A, et al. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology 2003;60:449-457.
5. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
6. Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 2002;59:1034-1041.
7. Gussekloo J, Westendorp RGJ, Remarque EJ, Lagaay AM, Heeren TJ, Knook DL. Impact of mild cognitive impairment on survival in very elderly people: cohort study. BMJ 1997;315:1053-1054.
8. Knopman DS, Parisi JE, Salviati A, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003;62:1087-1095.
9. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
10. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
11. Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321:1364-1371.
12. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 1997;49:1580-1587.
13. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state:" a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
15. Welsh KA, Butters NC, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part V: a normative study of the neuropsychological battery. Neurology 1994;44:609-614.
16. Albert MS, Smith L, Scherr P, Taylor J, Evans DA, Funkeastein H. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
17. Wechsler D. Wechsler Memory Scale-revised manual. San Antonio, TX: Psychological Corp., 1987.
18. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea and Febiger, 1983.
19. Nelson HE. National Adult Reading Test (NART) manual. Windsor, UK: NFER-NELSON Publishing Co., 1982.
20. Ekstrom RB, French JW, Harman HH, Kermen D. Manual for kit of factor-referenced cognitive tests. Princeton, NJ: Educational Testing Service, 1976.
21. Cooper JA, Sager HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991;114:2095-2122.
22. Craik FIM. A functional account of age differences in memory. In: Klix E, Hagendorf H, eds. Human memory and cognitive capabilities: mechanisms and performances. Amsterdam: Elsevier Science Publishers BV, 1986;409-422.
23. Smith A. Symbol Digit Modalities Test manual-revised. Los Angeles: Western Psychological Services, 1982.
24. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1992.
25. Raven JC, Court JH, Raven J. Manual for Raven's progressive matrices and vocabulary scales. Oxford, UK: Oxford University Press, 1992.
26. McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
27. Mitchell TW, Mufson EJ, Schneider JA, et al. Parahippocampal tau pathology in healthy aging, mild cognitive impairment and early Alzheimer's disease. Ann Neurol 2002;51:182-189.
28. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies - Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
29. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
30. Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to cognitive function in older persons. Neurology 2003;60:1909-1915.
31. Bennett DA, Wilson RS, Schneider JA, et al. Apolipoprotein E4 allele, Alzheimer's disease pathology, and the clinical expression of Alzheimer's disease. Neurology 2003;60:246-252.
32. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259.
33. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
34. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 1997;18(4 suppl):S1-2.
35. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer's disease pathology. Neurology 2004;62:1148-1155.
36. Schneider JA, Bienias J, Gilley DW, Kvarnberg D, Mufson EJ, Bennett DA. Improved detection of neurofibrillary pathology in Alzheimer's disease. J Histochem Cytochem 2002;50:99-106.
37. SAS Institute. SAS/STAT user's guide, version 8. Cary, NC: SAS Institute, 2000.
38. Guillozet AL, Weintraub S, Mash DC, Mesulam MM. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003;60:729-736.
39. DeKosky ST, Ikonomovic M, Styren S, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002;51:145-155.